Search results for: 'cell analyzer'
- Did you mean
- cell analyz
- cell analyzers
- Related search terms
- cell biolog research market global 2024 2030
- cell biolog research market global 2014 2030
- cell biolog research market global 2014 2020
- cell biolog research market global 2030 2030
- cell biolog research market global 2014 2024
-
11 Jul 2025  |  Global  |  Market Outlook
Global Pharmaceutical Industry Outlook, 2025
Industry Convergence and Technology Adoption Lead to Transformational Growth
In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...
$4,950.00
Special Price $4,455.00 save 10 %
-
03 Aug 2021  |  Global  |  Market Outlook
Global Automotive Outlook, 2021
Global Light Vehicle Sales are Expected to Rebound in 2021 and Witness a Healthy 8% Growth, Setting the Stage for the Industry to Overtake 2019 Levels by 2023
2020 was a defining year for the mobility industry in many ways. After a challenging 2018 and 2019, the pandemic threw the industry into a tailspin that saw global automotive sales falling to record lows in the first half of 2020. Several business models stuttered, and revenues hit a downward spiral. However, stakeholders have shown greater resilie...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Oct 2021  |  Global  |  Market Research
Global Electric Light Commercial Vehicle Growth Opportunities
Rising Demand, Innovation, and Competition Accelerating Future Growth Potential of Electric Light Commercial Vehicles
This Frost & Sullivan research service provides an overview of the electric light commercial vehicle (e-LCV) market in North America, Europe, China, and Asia-Pacific, presenting growth opportunities, comparisons between select models, sales percentage forecasts, and total cost of ownership (TCO) analysis. The e-LCV market across these regions is ex...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Oct 2021  |  Global  |  Technology Research
Global Neurological Therapies Growth Opportunities
Need for Effective Palliative Management Driving Technology Advances in Neurological Disease Drug Development
Neurological diseases refer to disorders of the brain, nerves, and spinal cord that lead to structural, biochemical, or electrical complications in the body. Major causes of neurological disorders include brain, spinal cord, or nerve injury; genetic disorders; congenital abnormalities; infections; and lifestyle. Neurological diseases include an ext...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Dec 2021  |  Global  |  Technology Research
Emerging Protein Alternatives for Dairy Industry: Technology Analysis
Consumer Demand for Alternatives to Animal-based Dairy Products Drive Growth Opportunities for Plant-based Proteins
Next-generation buyers, primarily millennials and Gen Z, follow a healthier consumption pattern and tend to reduce their meat consumption for both sustainable and diet reasons. The rising number of lactose-intolerant people and the growing concern for animal welfare explain the rising number of health-conscious people and the global shift in prefe...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Nov 2023  |  Global  |  Market Research
Global Precision Oncology Market Trends and Growth Opportunities
Public-private Partnerships Will Propel Access and Adoption of Precision Oncology Enhancing the Potential for Integrated Services and Solutions
The procedure for accurately identifying a biomarker correlation based on a patient s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treat...
$2,450.00
Special Price $1,837.50 save 25 %
-
23 Jan 2023  |  Global  |  Market Outlook
Top 10 for 2023: Predictions for the Global Commercial Vehicles Industry
Predictions for the Commercial Vehicles Market
The commercial vehicle industry is at the cusp of a major transformation that will change the dynamics of the supply chain and logistics industry. Frost & Sullivan has examined the top 10 CV trends that will have the highest impact on the commercial vehicle market in the upcoming years. The CASE (connected, autonomous, safe, and electric) strate...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Feb 2024  |  Global  |  Market Research
Innovations in Small Molecule Drug Delivery and Formulation
Disruptive Technologies Drive Growth Opportunities for New Product Launches
Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Jun 2024  |  Global  |  Market Outlook
2024 Prediction of the Global Electric Car Growth Outlook
The Electric Vehicle Industry Will Suffer Growth Deceleration as OEMs Fight a Price War
This Frost & Sullivan analysis provides an outlook for the electric vehicle (EV) industry based on the latest industry data, an outline of current trends, an in-depth examination of future developments, and a breakdown of the main stakeholders in the sector and their performance. EV sales in 2023 amounted to a total of 14.1 million, of which 70....
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Mar 2026  |  Global  |  Market Research
Growth Opportunities in Global Pharmaceutical Industry, 2026
Platforms, Policies, and Pathways: Convert Complexity into Growth
The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...
$4,950.00